Patrick Lim Soo

Title: Inventor Spotlight: Patrick Lim Soo

Introduction

Patrick Lim Soo is an accomplished inventor based in Ridgewood, NJ, who holds an impressive portfolio of 8 patents. His innovative contributions to the field of therapeutics demonstrate a significant understanding of the complexities involved in drug delivery systems, emphasizing the necessity of targeted treatments.

Latest Patents

Among his latest patents are groundbreaking technologies involving targeted conjugates and particles, as well as pharmaceutical formulations that contain these novel constructs. His work focuses on nanoparticles and microparticles that incorporate active agents, such as therapeutic, prophylactic, or diagnostic agents, linked to targeting moieties, notably somatostatin receptor binding moieties. These innovations are designed to enhance the temporospatial delivery of active agents, thereby improving biodistribution, crucial in the treatment or prevention of conditions like cancer and infectious diseases. His patent also outlines methods for creating these conjugates, particles, and formulations, as well as their administration to subjects needing such interventions.

Another significant patent relates to SSTR-targeted conjugates and particles, specifically focusing on the active agent DM1. By attaching this agent to a somatostatin receptor binding moiety via a linker, the resulting particles are capable of providing improved delivery, biodistribution, and tumor penetration while aiming to decrease toxicity. This patent similarly describes the methodologies behind the creation and application of these formulations.

Career Highlights

Patrick Lim Soo has made noteworthy strides in his career through his work with companies such as Tarveda Therapeutics, Inc. and Placon Therapeutics, Inc. His contributions in these roles have been instrumental in advancing therapeutic solutions that leverage innovative drug delivery mechanisms.

Collaborations

Throughout his career, Patrick has collaborated with esteemed colleagues, including Rossitza Gueorguieva Alargova and Mark T Bilodeau. These partnerships have facilitated the exchange of knowledge and ideas, further enhancing his innovative pursuits in the pharmaceutical domain.

Conclusion

Patrick Lim Soo exemplifies the essence of an innovative inventor, with a focus on enhancing therapeutic efficacy through advanced drug delivery systems. His dedication to developing targeted formulations reflects a commitment to improving patient outcomes in the medical field. As he continues to build upon his impressive portfolio, the impact of his inventions is sure to resonate within the industry, paving the way for future advancements in therapeutics.